ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE and DISEASE RECURRENCE

Overview

DISEASE RECURRENCE is the #2 most commonly reported adverse reaction for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, manufactured by The Procter & Gamble Manufacturing Company. There are 135 FDA adverse event reports linking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE to DISEASE RECURRENCE. This represents approximately 4.0% of all 3,372 adverse event reports for this drug.

Patients taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE who experience disease recurrence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DISEASE RECURRENCE is moderately reported among ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE

In addition to disease recurrence, the following adverse reactions have been reported for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE:

• COVID 19 — 173 reports
• NASOPHARYNGITIS — 123 reports
• FATIGUE — 101 reports
• COUGH — 98 reports
• NAUSEA — 88 reports
• DRUG INEFFECTIVE — 79 reports
• DIZZINESS — 75 reports
• DIARRHOEA — 71 reports
• HEADACHE — 69 reports
• VOMITING — 69 reports

Other Drugs Associated with DISEASE RECURRENCE

The following drugs have also been linked to disease recurrence in FDA adverse event reports:

Does ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE cause DISEASE RECURRENCE?

DISEASE RECURRENCE has been reported as an adverse event in 135 FDA reports for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DISEASE RECURRENCE with ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE?

DISEASE RECURRENCE accounts for approximately 4.0% of all adverse event reports for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, making it one of the most commonly reported side effect.

What should I do if I experience DISEASE RECURRENCE while taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE?

If you experience disease recurrence while taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages